Continuous renal replacement therapy in neonates weighing less than 3 kg
Open Access
- 1 January 2012
- journal article
- Published by Korean Pediatric Society in Korean Journal of Pediatrics
- Vol. 55 (8) , 286-292
Abstract
Continuous renal replacement therapy (CRRT) is becoming the treatment of choice for supporting critically ill pediatric patients. However, a few studies present have reported CRRT use and outcome in neonates weighing less than 3 kg. The aim of this study is to describe the clinical application, outcome, and complications of CRRT in small neonates. A retrospective review was performed in 8 neonatal patients who underwent at least 24 hours of pumped venovenous CRRT at the Samsung Medical Center in Seoul, Korea, between March 2007 and July 2010. Data, including demographic characteristics, diagnosis, vital signs, medications, laboratory, and CRRT parameters were recorded. The data of 8 patients were analyzed. At the initiation of CRRT, the median age was 5 days (corrected age, 38(+2) weeks to 23 days), and the median body weight was 2.73 kg (range, 2.60 to 2.98 kg). Sixty-two patient-days of therapy were reviewed; the median time for CRRT in each patient was 7.8 days (range, 1 to 37 days). Adverse events included electrolyte disturbances, catheter-related complications, and CRRT-related hypotension. The mean circuit functional survival was 13.9±8.6 hours. Overall, 4 patients (50%) survived; the other 4 patients, who developed multiorgan dysfunction syndrome, died. The complications of CRRT in newborns are relatively high. However, the results of this study suggest that venovenous CRRT is feasible and effective in neonates weighing less than 3 kg under elaborate supportive care. Furthermore, for using potential benefit of CRRT in neonates, efforts are required for prolonging filter survival.Keywords
This publication has 38 references indexed in Scilit:
- Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous HemodiafiltrationThe Korean Journal of Internal Medicine, 2011
- Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calciumPediatric Nephrology, 2010
- Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation studyCritical Care, 2009
- Dialysis and pediatric acute kidney injury: choice of renal support modalityPediatric Nephrology, 2009
- Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation studyCritical Care, 2008
- Circuit lifespan during continuous renal replacement therapy: children and adults are not equalCritical Care, 2008
- Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolismThe Journal of Pediatrics, 2006
- Update on Dialytic Management of Acute Renal FailureJournal of Intensive Care Medicine, 2003
- Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulationPediatric Nephrology, 2002
- Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolismThe Journal of Pediatrics, 1991